News
Anti-IL1RAP ADC demonstrated potent anti-tumor efficacy and was well tolerated in pre-clinical modelsAnti-IL1RAP ADC targets IL1RAP, which is overexpressed in many tumors and their tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback